Wockhardt trades jubilantly on the bourses

Wockhardt is currently trading at Rs. 835.00, up by 113.20 points or 15.68% from its previous closing of Rs. 721.80 on the BSE. The scrip opened at Rs. 727.95 and has touched a high and low of Rs. 843.75 and Rs. 727.00 respectively. So far 2259155 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 1944.85 on 02-May-2013 and a 52 week low of Rs. 336.60 on 16-Dec-2013. Last one week high and low of the scrip stood at Rs. 843.75 and Rs. 623.00 respectively. The current market cap of the company is Rs. 9164.89 crore. The promoters holding in the company stood at 74.70%, while Institutions and Non-Institutions held 7.84% and 17.32% respectively. Wockhardt will resume manufacturing, selling and distributing the Fixed Dose Combination (FDC) of Dicyclomine Hydrochloride IP 10mg, Tramadol Hydrochloride IP 50mg & Acetamenophen IP 325mg after getting suspension revoke by the State Drug Controller in Himachal Pradesh.  Earlier, the company’s certain drugs had been suspended by the State Drug Controller in state of Himachal Pradesh. Wockhardt is one of the few companies with end to end integrated capabilities for its products, starting with the manufacture of the oral and sterile API’s, the dose forms and marketing through wholly owned subsidiary in the US, enabling the company to capture maximum value.